Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads  by Kikuchi, T. et al.
Osteoarthritis and Cartilage (2001) 9, 351–356
© 2001 OsteoArthritis Research Society International 1063–4584/01/040351+06 $35.00/0
doi:10.1053/joca.2000.0395, available online at http://www.idealibrary.com onEffects of high molecular weight hyaluronan on the distribution and
movement of proteoglycan around chondrocytes cultured in alginate
beads
T. Kikuchi*, H. Yamada† and K. Fujikawa*
*Department of Orthopaedic Surgery, National Defense Medical College
†Department of Orthopaedic Surgery, Fujita Health University, Second Hospital, 3-6-10 Otobashi,
Nakagawaku, Nagoya, 454-8509 Japan
Summary
Objective: To evaluate the effects of high molecular weight hyaluronan (HA) on the distribution and movement of proteoglycan (PG) formed
around rabbit chondrocytes cultured in alginate beads.
Design: Rooster comb-derived HA (MW 8×105 Da) was co-polymerized in alginate gel to study the direct effects of extrinsic HA on
chondrocytes. PG metabolism of rabbit chondrocytes cultured in alginate beads was examined by measuring the incorporation of [35S]sulfate
into glycosaminoglycan in two distinct regions, the cells with their cell-associated matrix (CM) and the further-removed matrix (FRM).
Immunohistochemical analysis was performed using monoclonal antibodies against chondroitin sulfate and keratan sulfate. Autoradiography
using degenerated cartilage tissue from the rabbit osteoarthritis (OA) model was performed to discover the effect of HA on the distribution
of newly-synthesized PG in the cartilage tissue.
Results: The incorporation of [35S]sulfate into newly-synthesized PG in the cells with CM decreased with the addition of 0.125–1.0 mg/ml HA,
while the incorporation in the FRM increased. These effects of HA on the distribution of newly-synthesized PG were the same either in
chondrocytes with CM or chondrocytes without CM. Immunohistochemical analysis showed that staining of PG in the CM was decreased and
staining in the FRM was increased in the HA treated group compared to the control group. Autoradiography using degenerated cartilage
tissue from the rabbit OA model indicated that [35S]-labeled macromolecules showed a more diffuse distribution in the HA treated group
compared with the control group.
Conclusion: These results indicate that extrinsic HA could affect the movement of newly-synthesized PG from the CM to the FRM in both
alginate beads and cartilage tissue. © 2001 OsteoArthritis Research Society International
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Hyaluronan (HA) is a glycosaminoglycan which is
distributed widely in a variety of tissues and has various
functions in the body. HA exists in synovial fluid in high
concentrations and plays a significant role in joint lubri-
cation. HA is also one of the major components in the
extracellular matrix of articular cartilage, where it interacts
with aggrecan and link protein to form large aggregates.
High molecular weight HA has been used in osteoarthritis
(OA) therapy for two decades, and there have been many
reports of its clinical efficacy1–4. The effects of HA on OA
have been also studied in animal models induced by
papain injection, joint immobilization, resection of anterior
cruciate ligament and menisectomy5–8. A marked inhibitory351effect of HA on cartilage degeneration was observed in all
these studies. There has been much argument as to
whether or not HA has chondroprotective effects in human
OA. Recent study using diagnostic arthroscopy has
reported that HA might delay the structural progression of
human knee OA9.
Various in vitro effects of HA on chondrocytes have been
reported10–17. For example, HA regulates the synthesis of
proteoglycan (PG), the most important extracellular matrix
in cartilage tissue, in rabbit chondrocytes culture18. HA
also affects the catabolic activity of cartilage matrix
through inducing the production of tissue inhibitor of
metalloproteinases-1 (TIMP-1) by bovine chondrocytes12.
It is believed that HA injected into the joint cavity attaches
to the surface of articular cartilage19, where it exerts these
chondroprotective effects. Extrinsic HA has been shown to
be able to penetrate into degenerated cartilage and reach
the surface of chondrocytes20. However, the effects of
extrinsic HA on the extracellular matrix metabolism of
chondrocytes are still not fully understood.
Techniques of three-dimensional culture of chondrocytes
in alginate beads have been developed to allow the cells to
maintain their differentiated status. Long-term cultures of
chondrocytes in alginate beads have been shown to
synthesize type II collagen and aggrecan characteristic of
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alginate beads is useful to examine PG aggregates in their
native state and also to study their turnover, since alginate
can be easily removed by depolymerization with a calcium
chelator. Depolymerization of the beads permits the separ-
ation of the cells with their cell-associated matrix (CM) from
matrix molecules which reside in matrix further removed
from chondrocytes (FRM). The CM is located around the
chondrocytes and consists of pericellular and territorial
matrix. The FRM is located further away from the chondro-
cytes and consists of interterritorial matrix. In this paper,
rabbit articular chondrocytes were cultured in alginate
beads containing extrinsic HA and the distribution and
movement of newly-synthesized PG studied.Materials and methods
CULTURE OF CHONDROCYTES IN ALGINATE BEADS
Chondrocytes from the full thickness of articular cartilage
from the femoral condyle, tibial plateau and humeral head
of 1-month-old Japanese white rabbits were cultured in
alginate beads as described previously23. Four rabbits
were used for four independent experiments. Briefly, cells
were released from the cartilage tissue with 0.4% Pronase
(Kaken Pharmaceutical Co., Ltd, Tokyo) and 0.025%
bacterial collagenase P (Boehringer Mannheim, GmbH,
Germany) after digestion at 37°C for 12 h. Chondrocytes
were resuspended at a density of 2×106 cells/ml in a 1.2%
solution of sterile alginate (Kelco, Chicago, IL) in 0.15 M
NaCl. The cell suspension was slowly expressed through a
22-gauge needle dropwise into a 102 mM calcium chloride
solution. The beads were allowed to polymerize in this
solution for 10 min before two consecutive washes with
0.15 M NaCl followed by two washes in Dulbecco’s
modified Eagle’s medium (DMEM).INCORPORATION OF [35S]SULFATEChondrocytes without an established CM
Freshly isolated chondrocytes were encapsulated in
alginate beads containing designated concentrations of
rooster comb-derived HA (MW 8×105 Da, Seikagaku Co.,
Ltd, Tokyo). Briefly, HA was dissolved in physiological
saline containing 1.2% alginate at final concentrations of
0.125, 0.25, 0.5 or 1 mg/ml. Physiological saline was used
as control. Chondrocytes were suspended at a density of
2×106 cells/ml in HA solution containing 1.2% alginate and
beads were formed as described above. After washing,
beads containing the chondrocytes were then placed into
24-well culture plates (10 beads/well) in 1 ml of DMEM
containing 10% fetal bovine serum (FBS), 100 units/ml
penicillin G sodium, 100 g/ml streptomycin sulfate,
0.25 g/ml fungizone, 50 g/ml ascorbic acid and the same
concentration of HA as in the beads. Cells were pulsed with
2 Ci/ml of [35S]sulfate (NEN Life Science Products, Inc.
Ma, U.S.A.) at 37°C in a humidified atmosphere of 5% CO2
for 24 h. Medium was then removed from individual wells,
and the beads were dissolved by incubation for 10–15 min
at 4°C in 10 vol. of dissolving solution (55 mM sodium
citrate, 30 mM Na2EDTA, 0.15 M NaCl, pH 6.8). The result-
ing suspension was centrifuged at 900 rpm for 10 min at
4°C to separate the chondrocytes with their CM from
constituents of the FRM. In this procedure, chondrocytes
with their CM were recovered in the pellet and the FRMwas recovered in the supernatant. The cell pellet and
supernatant were treated separately for 48 h at 4°C with
4 M guanidine HCl in the presence of proteinase inhibitors
(10 mM Na2EDTA, 0.1 M 6-aminohexanoic acid, 5 mM
benzamidine hydrochloride, 10 mM N-ethylmaleimide and
0.5 mM phenylmethylsulfonyl fluoride) to extract [35S]-
labeled PG. [35S]-labeled PG in samples was measured as
described by Masuda et al.24 Briefly, into a well of 96-well
MultiScreen filtration plate (Millipore, Bedford, MA, U.S.A.),
75 l of the dilution buffer was pipetted with 25 l of the
sample and 150 l of the alcian blue dye solution. After the
plate had been gently agitated for 1 h at room temperature,
the liquid was filtered through a Millipore Durapore mem-
brane. Following a brief rinsing step, the membrane disc
was punched out into a scintillation vial and 500 l of the
dissolving buffer was added, followed by gentle shaking for
1 h at room temperature to dissociate and solubilize the
[35S]-labeled PG bound to alcian blue. After 2.5 ml of
scintillation fluid was added, the radioactivity of each vial
was measured in a scintillation counter.Chondrocytes with an established CM
The alginate beads containing freshly isolated chondro-
cytes were cultured in DMEM containing 10% FBS,
100 units/ml penicillin G sodium, 100 g/ml streptomycin
sulfate, 0.25 g/ml fungizone, 50 g/ml ascorbic acid for 5
days to form a CM around the cells. Beads were then
dissolved, the cell suspension centrifuged (900 rpm,
10 min) and chondrocytes with their CM recovered in the
pellet. The chondrocytes with their CM were resuspended
in a 1.2% solution of sterile alginate in 0.15 M NaCl
containing designated concentrations of HA, and beads
were formed by expressing through a 22-gauge needle as
mentioned above. The beads were transferred into DMEM
containing 10% FBS, 100 units/ml penicillin G sodium,
100 g/ml streptomycin sulfate, 0.25 g/ml fungizone,
50 g/ml ascorbic acid and the same concentration of
HA as in the beads. Cells were pulsed with 2 Ci/ml
of [35S]sulfate for 24 h and [35S]sulfate incorporation
performed as described for chondrocytes without CM.MEASUREMENT OF DNA CONTENT
The DNA content of chondrocytes were measured using
the bisbenzimidazole fluorescent dye (Hoechst 33258,
Polyscience, Warrington, PA) as described previously25.
Briefly, alginate beads containing chondrocytes were
treated with papain (10 g/ml in 0.1 M Na acetate, 50 mM
EDTA, 5 mM cysteine-HCl, pH=5.53) overnight at 60°C.
Each digest (100 l) was mixed with 100 l of phosphate-
buffered saline (PBS) and 1.75 ml of the dye solution
(0.2 g/ml of Hoechst 33258 in 0.01 M Tris, 1 mM EDTA,
0.1 M NaCl). Fluorescence was measured using a
spectrofluorometer (emission 415 nm, excitation 365 nm).
Standard curves were generated using known concen-
trations of calf thymus DNA.IMMUNOHISTOCHEMISTRY
Chondrocytes freshly isolated from cartilage were cul-
tured in alginate beads for 5 days with or without 1 mg/ml
HA. These beads were immediately fixed in 4% paraformal-
dehyde buffer (pH 7.4) containing 4% cetylpyridinium
chloride, 10 mM CaCl for 4 h at 20°C. The fixed beads2
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(pH 7.4) containing 50 mM BaCl2, and then dehydrated in a
series of graded ethanol washes followed by a xylene
wash. Samples were then embedded in paraffin. Sections
(4 m) were cut, air dried, deparaffinized, rehydrated and
incubated for 10 min in PBS. The sections were immuno-
stained with the immunofluorescence method using a
specific monoclonal anti-chondroitin sulfate antibody
(1/100 dilution, CS-56, Seikagaku Co., Ltd) as described
previously26. Sections were digested with chondroitinase
ABC (0.5 unit/ml in PBS, pH 7.4, Seikagaku Co., Ltd) prior
to keratan sulfate staining using an anti-keratan sulfate
monoclonal antibody (1/100 dilution, 5-D-4, Seikagaku Co.,
Ltd). To study chondrocytes without their FRM, cells were
cultured in alginate beads for 5 days in DMEM. Beads were
dissolved, chondrocytes with their CM were recovered in
pellets, re-encapsulated in alginate gel and then immedi-
ately fixed in 4% paraformaldehyde buffer. The same
immunohistological staining was then performed as
described above.AUTORADIOGRAPHY USING DEGENERATED CARTILAGE FROM A
RABBIT OA MODEL
Experimental OA was induced in the knee joints of two
female 3–4-month-old Japanese white rabbits weighing
2–2.5 kg, by partial lateral menisectomy according to the
method described by Colombo et al.27 Two weeks post-
operation, the cartilage from lateral femoral condyle and
tibial plateau showed degenerative changes including loss
of superficial layer, erosion, fibrillation and/or fissures,
disorganization of chondrocytes and cluster formation. No
cartilage changes developed in either the medial femoral
condyle or the medial tibial plateau. Degenerated cartilage
tissue (2 mm×2 mm, full thickness) obtained from lateral
tibial plateau was cultured in DMEM containing 10% FBS
and [35S]sulfate (10 Ci/ml) for 48 h with or without HA
(1 mg/ml). Cartilage tissue was then fixed with 10% para-
formaldehyde buffer (pH 7.4) containing 4% cetylpyridinium
chloride and frozen sections (4 m) were cut. These
sections were subjected to autoradiography as described
previously28. Briefly, slides were dipped in NTB2 emulsion
(Eastman Kodak Co., Rochester, NY), diluted 1:1 with
600 mM ammonium acetate and exposed for 8–12 days.
The emulsion was developed in D-19 (Eastman Kodak
Co.), diluted 1:1 with distilled water at 16°C. Sections were
counterstained with cresyl violet acetate and coverslipped.STATISTICAL ANALYSIS
The means and S.D. were calculated from four separate
cultures. The statistical significance of intergroup differ-
ences was analysed by ANOVA. Differences were
considered significant if P<0.05.ResultsINCORPORATION OF [35S]SULFATE INTO PROTEOGLYCANSChondrocytes without an established CM
Incorporation of [35S]sulfate into PG was first measured
in freshly isolated chondrocytes which had no established
CM. In the control group, incorporation of [35S]sulfate into
newly synthesized PG of the cells with CM was 74.8% ofthe total and that of the FRM was 22.2% of the total.
Incorporation of [35S]sulfate into PG of the cells with CM
decreased with the addition of HA to 52.2% of the total
incorporation in the presence of 1 mg/ml HA (Fig. 1). In
contrast [35S] incorporation into PG of the FRM increased
with the addition of HA, reaching 44.8% of the total incor-
poration in the presence of 1 mg/ml HA (Fig. 1). Release of
radiolabeled material into the culture medium was con-
stantly less than 5% of the total incorporated during the
course of the experiment.Chondrocytes with an established CM
Chondrocytes were allowed to establish a CM for 5 days
in alginate before [35S]sulfate incorporation into PG was
measured. In the control group, the incorporation of
[35S]sulfate into newly synthesized PG of the cells with CM
was 73.3% of the total and that of the FRM was 23.7% of
the total (Fig. 2). [35S]sulfate incorporation into PG of the
cells with CM decreased with the addition of HA reaching
54.5% of the total in the presence of 1 mg/ml of HA (Fig. 2).
[35S]sulfate incorporation into PG of the FRM increased
with the addition of HA reaching 42.5% of the total in the
presence of 1 mg/ml HA (Fig. 2). In the time course of this
experiment, the release of radiolabeled material into the
culture medium was constantly less than 4% of the total
incorporated.Fig. 1. Effects of HA on [35S]sulfate incorporation into PG in
chondrocytes without an established CM. Freshly isolated
chondrocytes were encapsulated in alginate beads containing
designated concentrations of rooster-comb HA. Pulse-labeling was
performed with [35S]sulfate for 24 h. The beads were dissolved and
the resulting suspension was centrifuged to separate the chondro-
cytes with their CM from constituents of the FRM. The cell pellet
and supernatant were separately treated with 4 M guanidine HCl to
extract [35S]labeled PG from each fraction. [35S]labeled PG in
samples was measured as described by Masuda et al.24 Data
represent the mean (±S.D.) of four independent cultures.IMMUNOHISTOCHEMISTRY
Chondrocytes cultured in alginate beads for 5 days in the
presence or absence of HA (1 mg/ml) were examined
immunohistochemically. The encapsulated chondrocytes
exhibited a spherical morphology like suspended cells both
in the absence [Fig. 3(a)] or the presence [Fig. 3(b)] of HA.
In controls, monoclonal antibodies against chondroitin sul-
fate showed diffuse and granular staining seen further
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ing the beads to remove the FRM resulted in thin staining
with a ring-like pattern in the close vicinity of the chondro-
cytes [Fig. 3(d)], indicating that the thin staining with aring-like pattern reflects the CM and the diffuse and
granulat staining the FRM. In HA treated cells, the diffuse
granular staining was stronger [Fig. 3(e)]. As seen for the
controls, dissolving the beads removed the FRM, as the
diffuse granular staining pattern disappeared [Fig. 3(f)].
Immunohistochemical analysis using monoclonal anti-
bodies against keratan sulfate showed similar staining
patterns both in the presence and absence of HA (figure not
shown).
Autoradiography using degenerated cartilage from the
rabbit OA model. In the control group, most of the [35S]-
labeled macromolecules in the degenerated cartilage
tissue were observed within the pericellular and territorial
matrix [Fig. 4(a)]. In the HA treated group, while [35S]-
labeled macromolecules in the pericellular and territorial
matrix were still present at high concentrations, the
proportion of [35S]-labeled macromolecules in the inter-
territorial matrix increased [Fig. 4(b)].Fig. 2. Effects of HA on [35S]sulfate incorporation into PG in
chondrocytes with an established CM. Alginate beads containing
freshly isolated chondrocytes were cultured in DMEM for 5 days to
form a CM around the cells. These beads were then dissolved, and
chondrocytes with their CM were recovered in the pellet. The
chondrocytes with CM were then resuspended in an alginate
solution containing designated concentrations of HA, and beads
were reformed. [35S]sulfate incorporation was then performed as
described for Fig. 1. Data represent the mean (±S.D.) of four
independent cultures.Fig. 3. Immunohistochemistry of chondrocytes cultured in alginate beads. Chondrocytes freshly isolated from cartilage were cultured in
alginate beads for 5 days in the absence (a), (c) and (d) or the presence (b), (e) and (f) of 1 mg/ml HA. These beads were immediately fixed
in 4% paraformaldehyde buffer, then embedded in paraffin (a), (b), (c) and (e). Sections (4 m) were cut and immunostained using the
immunofluorescence method with a specific monoclonal anti-chondroitin sulfate antibody. To observe chondrocytes without their FRM, beads
were dissolved after 5 days in culture and chondrocytes with CM were re-encapsulated in alginate gel before being fixed (d) and (f). Four
independent experiments were performed and representative sections were shown.Discussion
High molecular weight HA has been used as an effective
treatment for OA. Two effects have been observed, its
physical effects on cartilage tissue and metabolic effects on
cellular function. HA has been shown physically to act as a
lubricant and shock absorber. These effects are dependent
on the high visco-elasticity of this molecule. HA also
has chondroprotective functions on joint cells including
chondrocytes and synoviocytes. It has been reported to
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synoviocytes, to inhibit the degradation and release of PG
in chondrocyte cultures, to increase the production of PG
and to inhibit the production of matrix metalloproteinases in
chondrocyte cultures18,29,30. We studied the effects of HA
on PG metabolism in chondrocytes, particularly the effects
on the distribution of newly-synthesized PG around the
cells in alginate beads.
It has been previously reported that in alginate bead
cultures, newly-synthesized PG in the CM form aggregates
with intrinsic HA21. These studies also reported that PG
secreted into the CM moves gradually into the FRM during
the time course of the culture. To study the effect of
extrinsic HA on chondrocyte matrix metabolism in three-
dimensional culture, chondrocytes were encapsulated
in alginate beads co-polymerized with HA. This co--
polymerization technique was employed because HA in the
medium is otherwise not able to penetrate the alginate gel
to reach the proximity of the cell surface due to the
molecular sieve effect of the alginate gel. Our results show
that PG concentration in the cells with CM decreased with
the addition of HA while PG concentration in the FRM
increased. Direct contact of extrinsic HA with the cell
surface did not seem to be essential for these effects of HA,
since similar results were observed for both chondrocytes
with and without an established CM. The effect of HA on the
distribution of newly-synthesized PG was demonstrated
both by measurement of the [35S]labeled PG in the two
distinct areas and by immunohistochemical analysis using
monoclonal antibodies against CS and KS, which are
representative side chains of aggrecan.
It has been reported that PG produced by chondrocytes
has low affinity for HA when it is first secreted, changing to
a high-affinity form before binding to HA31. It has also been
reported that in alginate bead cultures, PG in the FRM had
a lower affinity for HA and/or link protein than PG in the
CM21. With the co-polymerization of extrinsic HA in alginate
beads, the newly-synthesized PG moved significantly from
the CM to the FRM. The exact mechanism of this effect of
HA on PG distribution could not be elucidated in this study.
However, it may be partly explained by the inhibition of
conversion of the low-affinity form of PG to a high-affinityform with the addition of extrinsic HA. This inhibition may
cause newly-synthesized PG from chondrocytes to move
more rapidly from the CM to the FRM. To study if extrinsic
HA had the same effects on PG metabolism in cartilage
tissue as that observed in alginate gel, degenerated carti-
lage tissue obtained from a rabbit knee OA model was
pulse-labeled with [35S]sulfate. Extrinsic HA increased the
movement of [35S]labeled macromolecules from the
pericellular/territorial matrix to the interterritorial matrix,
suggesting that the same phenomenon would occur in vivo
by the intraarticular injection of HA. It is not clear if these
effects of extrinsic HA on PG metabolism in this study will
benefit in the therapy for OA. The pericellular and territorial
matrices play important roles in maintaining the cellular
microenvironment of chondrocytes, however the interterri-
torial matrix constitutes the largest proportion in articular
cartilage. The physical property of cartilage thus depends
mainly on the interterritorial matrix. HA increased the move-
ment of newly-synthesized PG from the CM to the FRM in
alginate gel and increased the PG content in the FRM.
These effects of HA could assist in strengthening the
interterritorial matrix in cartilage tissue by increasing its PG
content, and may aid in the therapy for OA.Fig. 4. Autoradiography using degenerated cartilage from a rabbit OA model. Experimental OA was induced in the knee joints of Japanese
white rabbits by partial lateral menisectomy. Degenerated cartilage tissue obtained from lateral tibial plateau of this OA model was
pulse-labeled with [35S]sulfate for 48 h in the absence (a) or the presence (b) of 1 mg/ml HA. Cartilage tissue was then fixed with 10%
paraformaldehyde buffer, and frozen sections were cut. These sections were then subjected to autoradiography.References
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